Infectious endocarditis due to Yersinia enterocolitica.

Abstract

Yersinia enterocolitica is a gram-negative coccobacillus. Y. enterocolitica infection is acquired by humans via the oral route. Infection due to Y. enterocolitica was first observed in 1933 in New York. Y. enterocolitica septicemia has been increasingly recognized in recent years, whereas endocarditis due to Y. enterocolitica is a rare manifestation. We herein describe a patient who developed Y. enterocolitica endocarditis and was successfully treated with a combination of drugs consisting of a quinolone (ofloxacin) and an aminoglycoside (netilmicin).

• Authors: G Karachalios, G Bablekos, G Karachaliou, A K Charalabopoulos, K Charalabopoulos
• Journal: Chemotherapy (Chemotherapy) Vol. 48 Issue 3 Pg. 158-9 (Jul 2002) ISSN: 0009-3157 [Print] Switzerland
• PMID: 12138334 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright 2002 S. Karger AG, Basel

Chemical References

• Anti-Bacterial Agents
• Anti-Infective Agents
• Netilmicin
• Ofloxacin

Topics

• Anti-Bacterial Agents (therapeutic use)
• Anti-Infective Agents (therapeutic use)
• Drug Therapy, Combination
• Endocarditis, Bacterial (drug therapy, microbiology, pathology)
• Humans
• Male
• Middle Aged
• Netilmicin (therapeutic use)
• Ofloxacin (therapeutic use)
• Treatment Outcome
• Yersinia Infections (drug therapy, microbiology, pathology)
• Yersinia enterocolitica (pathogenicity)